Antibe Therapeutics Inc. (ATBPF) .
本页证实的标准:
SharesGrow 综合评分： 26/100 其中 0/7 项标准通过。
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2014 | $-1.02 | $0.00 | $-2.68M | - |
| 2015 | $-1.19 | $19.96K | $-4.4M | -22052.4% |
| 2016 | $-0.42 | $4.44M | $-3.37M | -75.8% |
| 2017 | $-0.60 | $9.05M | $-5.75M | -63.5% |
| 2018 | $-0.49 | $8.51M | $-7.43M | -87.3% |
| 2019 | $-0.60 | $9.54M | $-12.82M | -134.4% |
| 2020 | $-0.71 | $9.67M | $-19.34M | -200.1% |
| 2021 | $-0.70 | $9.71M | $-26.3M | -270.8% |
| 2022 | $-0.49 | $0.00 | $-25.06M | - |
| 2023 | $-0.37 | $0.00 | $-19.48M | - |
